鉴于基本面强劲,沃特世公司(NYSE:WAT)股价疲软会是暂时现象吗?- 雅虎财经
Will Weakness in Waters Corporation's (NYSE:WAT) Stock Prove Temporary Given Strong Fundamentals? - Yahoo Finance
生物技术与制药领域的最新动态
Will Weakness in Waters Corporation's (NYSE:WAT) Stock Prove Temporary Given Strong Fundamentals? - Yahoo Finance
Roche achieves first CLIA 'Moderate Complexity' categorization for Ionify® 25-Hydroxy Vitamin D total test - PR Newswire
Roche to acquire liver drug developer 89bio for up to $3.5 billion - Reuters
Roche dives into MASH with $2.4B deal for 89bio - BioPharma Dive
2025 Thermo Fisher Scientific Junior Innovators Challenge Finalists - societyforscience.org
Thirty inspiring middle school scientists and engineers shine as finalists in the Thermo Fisher Scientific Junior Innovators Challenge - societyforscience.org
Lonza Group AG's (VTX:LONN) 3.4% loss last week hit both individual investors who own 50% as well as institutions - Yahoo Finance
Lonza Appoints Jason Berndt as Head of Group Operations - Contract Pharma
Top 10 Contract Development and Manufacturing Organizations 2025 - GEN - Genetic Engineering and Biotechnology News
Cytiva supports University of Hyderabad to drive innovations in sustainable food tech - FFOODS Spectrum
Bioprocess 5.0: Straddles the Human-AI Divide to Scale Next-Gen Therapies - GEN - Genetic Engineering and Biotechnology News
Process Monitors and Controls Shift Towards Unified Platforms - GEN - Genetic Engineering and Biotechnology News
How an Illumina bioinformatics engineer contributes to the company mission - Illumina
Cytiva Top of Utah Marathon - Cache Valley Daily
Cytiva and WhiteLab Genomics team up to use AI to accelerate cell line development - BioSpectrum Asia
Lonza’s UC-II Collagen earns NutraStrong certification, backed by clinical evidence on knee flexibility - Nutritional Outlook
Lonza CHI receives NutraStrong Collagen Verified certification - nutritioninsight.com
Executive changes at Lonza - The Pharma Letter
Manufacturing Challenges with High-Concentration Biologics - GEN - Genetic Engineering and Biotechnology News
One Year After Illumina/Grail – How Are EU Competition Authorities Now Dealing With Below-Threshold Mergers - Crowell & Moring LLP